ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine

Ulker, Mehmet; Duman, Berna; ŞAHİN, BERKSOY; GÜMÜRDÜLÜ, DERYA

doi:10.5114/wo.2015.52656

ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine

Copy For Citation

Ulker M., Duman B. B., ŞAHİN B., GÜMÜRDÜLÜ D.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.19, no.3, pp.207-213, 2015 (ESCI)

Publication Type: Article / Article
Volume: 19 Issue: 3
Publication Date: 2015
Doi Number: 10.5114/wo.2015.52656
Journal Name: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.207-213
Çukurova University Affiliated: Yes

Abstract

Background: We aimed to investigate the impact of RRM1 and ERCC1 expression on response to cisplatin and/or gemcitabine chemotherapy in patients with lung, ovarian or pancreatic cancer.